TY  - GEN
AU  - Jabbour,E
AU  - Hochhaus,A
AU  - Cortes,J
AU  - La Rosée,P
AU  - Kantarjian,H M
TI  - Choosing the best treatment strategy for chronic myeloid leukemia patients resistant to imatinib: weighing the efficacy and safety of individual drugs with BCR-ABL mutations and patient history
SN  - 1476-5551
PY  - 2010///0127
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Benzamides
KW  - Dasatinib
KW  - Drug Resistance, Neoplasm
KW  - Fusion Proteins, bcr-abl
KW  - genetics
KW  - Humans
KW  - Imatinib Mesylate
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Mutation
KW  - Piperazines
KW  - adverse effects
KW  - Protein Kinase Inhibitors
KW  - Pyrimidines
KW  - Thiazoles
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.1038/leu.2009.193
ER  -